Answer
The most frequent adverse reactions to sarilumab in patients with rheumatoid arthritis or polymyalgia rheumatica are neutropenia (14.3%), upper respiratory infections (6.8%), increased ALT (6.3%), urinary tract infections (5.3%) and injection-site erythema (5.0%).
Sources for this answer
- Kevzara 150 mg solution for injection in pre-filled penSANOFI · emc · SmPC §4.8 Undesirable effects · Version 3Document updated
Sources checked